User charges require objective analysisBMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c5303 (Published 29 September 2010) Cite this as: BMJ 2010;341:c5303
- Michael A Soljak, postgraduate researcher1
- 1Department of Primary Care and Public Health, Imperial College London, London W6 8RP, UK
Thomson and colleagues explain how charges are being refined to reduce low value care in Europe but conclude that the UK does not need this strategy because it uses others.1 To reduce low value care, every effective strategy is needed.
User charges for prescriptions in the UK raise about £1bn (€1.17bn; $1.57bn) annually. The efficiency …